Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael A Postow

Showing results (31-40 of 212) with videos related to

Pageof 22
Sort By:
The Oncologist|April 5, 2022
Efficacy of Infliximab Dose Escalation in Patients with Refractory Immunotherapy-Related Colitis: A Case SeriesJessica P Harris, Michael A Postow, David M Faleck
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 17, 2012
The antitumor immunity of ipilimumab: (T-cell) memories to last a lifetime?Michael A Postow, Margaret K Callahan, Jedd D Wolchok
Clinics in Dermatology|February 27, 2013
Immunomodulatory therapy for melanoma: ipilimumab and beyondMargaret K Callahan, Michael A Postow, Jedd D Wolchok
Cancer Treatment and Research|November 26, 2015
Checkpoint Blockade for the Treatment of Advanced MelanomaMargaret K Callahan, Catherine R Flaherty, Michael A Postow
Immunity|May 19, 2016
Targeting T Cell Co-receptors for Cancer TherapyMargaret K Callahan, Michael A Postow, Jedd D Wolchok
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 18, 2021
Facts and Hopes in Prediction, Diagnosis, and Treatment of Immune-Related Adverse EventsJames W Smithy, David M Faleck, Michael A Postow
Cancer Journal (Sudbury, Mass.)|January 24, 2017
Radiotherapy and Immune Checkpoint Blockade for Melanoma: A Promising Combinatorial Strategy in Need of Further InvestigationFreddy E Escorcia, Michael A Postow, Christopher A Barker
Frontiers in Oncology|February 3, 2015
CTLA-4 and PD-1 Pathway Blockade: Combinations in the ClinicMargaret K Callahan, Michael A Postow, Jedd D Wolchok
Cancer|February 26, 2016
Irradiation and immunotherapy: From concept to the clinicApril K S Salama, Michael A Postow, Joseph K Salama
American Journal of Clinical Oncology|January 24, 2015
Immune-priming of the tumor microenvironment by radiotherapy: rationale for combination with immunotherapy to improve anticancer efficacyVafa Shahabi, Michael A Postow, David Tuck, et al.
Pageof 22

Showing results (31-40 of 212) with videos related to

Sort By:
Pageof 22
The Oncologist|April 5, 2022
Efficacy of Infliximab Dose Escalation in Patients with Refractory Immunotherapy-Related Colitis: A Case SeriesJessica P Harris, Michael A Postow, David M Faleck
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 17, 2012
The antitumor immunity of ipilimumab: (T-cell) memories to last a lifetime?Michael A Postow, Margaret K Callahan, Jedd D Wolchok
Clinics in Dermatology|February 27, 2013
Immunomodulatory therapy for melanoma: ipilimumab and beyondMargaret K Callahan, Michael A Postow, Jedd D Wolchok
Cancer Treatment and Research|November 26, 2015
Checkpoint Blockade for the Treatment of Advanced MelanomaMargaret K Callahan, Catherine R Flaherty, Michael A Postow
Immunity|May 19, 2016
Targeting T Cell Co-receptors for Cancer TherapyMargaret K Callahan, Michael A Postow, Jedd D Wolchok
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 18, 2021
Facts and Hopes in Prediction, Diagnosis, and Treatment of Immune-Related Adverse EventsJames W Smithy, David M Faleck, Michael A Postow
Cancer Journal (Sudbury, Mass.)|January 24, 2017
Radiotherapy and Immune Checkpoint Blockade for Melanoma: A Promising Combinatorial Strategy in Need of Further InvestigationFreddy E Escorcia, Michael A Postow, Christopher A Barker
Frontiers in Oncology|February 3, 2015
CTLA-4 and PD-1 Pathway Blockade: Combinations in the ClinicMargaret K Callahan, Michael A Postow, Jedd D Wolchok
Cancer|February 26, 2016
Irradiation and immunotherapy: From concept to the clinicApril K S Salama, Michael A Postow, Joseph K Salama
American Journal of Clinical Oncology|January 24, 2015
Immune-priming of the tumor microenvironment by radiotherapy: rationale for combination with immunotherapy to improve anticancer efficacyVafa Shahabi, Michael A Postow, David Tuck, et al.
Pageof 22